ArticlePLOS global public health2026
Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in Liberia.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Long-term psychosocial sequelae of Ebola virus disease (EVD) survivors are poorly understood. We conducted a cross-sectional study of a cohort of EVD survivors and their uninfected contacts in Liberia. Beginning in November 2019, we consecutively sampled eligible participants until the end of the parent study follow up. Enrolled participants completed a questionnaire administered by trained study staff. Outcome measurements were symptoms of depression (PHQ-8) and anxiety (GAD-7) as well as experiences of trauma (PC-PTSD-5), food insecurity (HFIAS), and social support (Duke-UNC SSQ). Excess prevalence was defined as the difference in prevalence between survivors and contacts. We performed adjusted analyses with logistic regression models and restricted to the survivor population for assessment of risk factors. Our analysis cohort included 1,144 participants among whom 363 were Ebola survivors and 781 were contacts. Participants were sampled a median of 55 months (IQR: 51, 60) after enrollment in the parent study. Excess prevalence was as follows: 7.9% had severe food insecurity by HFIAS (18.5% EVD survivors vs. 10.6% contacts), 6.2% had any anxiety symptoms by GAD-7 (11.6% EVD survivors vs. 5.4% contacts), 3.7% had any depression symptoms by PHQ-8 (8.3% EVD survivors vs. 4.6% contacts), and 3.2% had probable PTSD by PC-PTSD-5 (4.5% EVD survivors vs. 1.3% contacts). Levels of support were similar between survivors and contacts. EVD survivors had a higher adjusted odds of scoring in a more severe category on the GAD-7 scale (adjusted odds ratio [AOR]: 3.60; 95% CI: 1.42, 9.16), PC-PTSD-5 scale (AOR: 3.26; 95% CI: 1.40, 7.58), and HFIAS scale (AOR: 1.84; 95% CI: 1.29, 2.61). Age, history of post-acute symptoms, and non-Ebola related trauma were risk factors for multiple psychosocial outcomes among survivors. We found significant but modest evidence of psychosocial sequelae among EVD survivors compared with contacts between four to five years after the acute illness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.